Menu
Recruiting NCT07446985

Is There a Benefit From Addition of Physical Exercise to Diet Restriction/Limitation in PCOS Women With Asthma?

No phase Interventional Polycystic Ovary Syndrome Asthma

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: exercise plus limiitng diet, limiting diet.
Who it may be relevant to
Registry conditions: Polycystic Ovary Syndrome, Asthma. Basic parameters: 20 years — 30 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Women with polysyctic ovarian syndrome (PCOS) usually develop many complications including asthma. Nowdays, diet restriction combimed with phsyical exercises may improve both problems

Detailed description

Forty Women with asthma with PCOS will be enrolled to be catogrized to Group I or group II. Group I will enroll twenty females with PCOS and asthma who will apply forty minutes walking on treadmill three times per week. Also Group I will follow low calorie diet and daily metformin for 12 weeks. Group II will will enroll twenty females with PCOS and asthma who will follow low calorie diet and daily metformin for 12 weeks

Interventions

  • Behavioral exercise plus limiitng diet
    Group I will enroll twenty females with PCOS and asthma who will apply forty minutes walking on treadmill three times per week. Also Group I will follow low calorie diet and daily metformin for 12 weeks.
  • Behavioral limiting diet
    Group II will will enroll twenty females with PCOS and asthma who will follow low calorie diet and daily metformin for 12 weeks

Primary outcome measures

  • forced vital capcity [Time frame: it will be measured after 12 weeks]
Secondary outcome measures (10)
  • forced expiratory volume [Time frame: It will be measured after 12 weeks]
  • forced expiratory volume to forced expiratory capcity [Time frame: It will be measured after 12 weeks]
  • body mass index [Time frame: It will be measured after 12 weeks]
  • waist circumference [Time frame: it will be measured after 12 weeks]
  • waist hip ratio [Time frame: It will be measured after 12 weeks]
  • Mini asthma quality of life questionnaire [Time frame: It will be measured after 12 weeks]
  • scale of fatigue severity [Time frame: It will be measured after 12 weeks]
  • luteinizing-hormone to follicle-stimulating-hormone ratio [Time frame: It will be measured after 12 weeks]
  • Testosterone [Time frame: It will be measured after 12 weeks]
  • Dehydroepiandrosterone [Time frame: It will be measured after 12 weeks]

Eligibility criteria

Inclusion criteria

  • PCOS women
  • women with asthma
  • obese women (calss I)

Exclusion criteria

  • cardiac problems
  • renal problems
  • liver problems

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Cairo University — Giza

Identifiers

NCT: NCT07446985 · IRB000-14233-69

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗